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Abstract 29 
Introduction: The placenta performs a range of functions to support fetal growth. In addition 30 
to facilitating nutrient transport, the placenta also stores glucose as glycogen, which is 31 
thought to maintain fetal glucose supply during late gestation. However, evidence to 32 
support such a role is currently lacking. Similarly, our understanding of the dynamics of 33 
placental glycogen metabolism in normal mouse pregnancy is limited. 34 
Methods: We quantified the placental glycogen content in wild type C57BL/6JOlaHsd mouse 35 
placentas from mid (E12.5) to late (E18.5) gestation, alongside characterising the temporal 36 
expression pattern of genes encoding glycogenesis and glycogenolysis pathway enzymes. To 37 
assess the potential of the placenta to produce glucose, we investigated the spatiotemporal 38 
expression of glucose 6-phosphatase by qPCR and in situ hybridisation. Separate analyses 39 
were undertaken for placentas of male and female conceptuses to account for potential 40 
sexual dimorphism. 41 
Results: Placental glycogen stores peak at E15.5, having increased over 5-fold from E12.5, 42 
before declining by a similar extent at E18.5. Glycogen stores were 17% higher in male 43 
placentas than in females at E15.5. Expression of glycogen branching enzyme (Gbe1) was 44 
reduced ~40% towards term. Expression of the glucose 6-phosphatae isoform G6pc3 was 45 
enriched in glycogen trophoblast cells and increased towards term. 46 
Discussion: Reduced expression of Gbe1 suggests a decline in glycogenesis, and specifically, 47 
glycogen branching towards term. Expression of G6pc3 by glycogen trophoblasts is 48 
consistent with an ability to produce and release glucose from glycogen stores. However, 49 
the ultimate destination of the glucose generated from placental glycogen remains to be 50 
elucidated. 51 
Highlights 
 Placental glycogen stores peak at embryonic day 15.5 and decline 4-fold by E18.5 
 Expression of glycogen branching enzyme Gbe1 declines ~40% from E12.5 
 The glucose 6 phosphatase isoform G6pc3 is expressed in the mouse placenta 
 G6pc3 expression is enriched in glycogen trophoblast cells 
 G6pc3 expression in glycogen cells is consistent with glucose production 
*Highlights
Introduction 50 
The placenta performs a diverse range of functions to support fetal growth whilst 51 
maintaining maternal well-being. In addition to facilitating nutrient transport from mother 52 
to fetus, the placenta also stores glucose as glycogen. Aberrant placental glycogen storage is 53 
often associated with fetal growth restriction (FGR) in mouse models [1], and in humans, 54 
elevated placental glycogen has been reported in diabetic pregnancies and pre-eclampsia 55 
[2-6]. However, the normal physiological role of placental glycogen stores remains unclear 56 
[reviewed in 1, 7]. The most widely accepted hypothesis is that placental glycogen 57 
represents a readily mobilised source of glucose to support fetal growth during late 58 
gestation [8, 9]. However, direct experimental evidence for such a role is currently lacking. 59 
The mouse is an ideal model in which to investigate the role of placental glycogen, 60 
with a short gestation, large litter size, and well-characterised placental development [10, 61 
11]. The mature mouse placenta comprises the maternal-derived decidua basalis (Db) and 62 
the fetal-derived labyrinth and junctional zones (Lz and Jz respectively) [10, 11]. The Lz 63 
facilitates nutrient and gas exchange whereas the Jz is predominantly endocrine in function. 64 
The Jz is primarily comprised of spongiotrophoblast (SpT) and glycogen trophoblast (GlyT) 65 
cells, both of which have an endocrine role, with GlyT also responsible for glycogen storage. 66 
GlyT are first observed around embryonic day (E) 6.5, identified by the presence of small 67 
quantities of glycogen detected by periodic acid-Schiff (PAS) staining [12, 13]. Beginning 68 
around E12.5, these “pre-GlyT” transition to mature GlyT, a process seemingly driven by 69 
expression of Gjb3 and Cdkn1c and marked by an increased accumulation of glycogen stores 70 
that results in the characteristic vacuolated appearance of GlyT by histology [14]. GlyT 71 
number increases nearly 300-fold between E12.5 and E16.5 before declining ~50% by E18.5 72 
[14]. From ~E12.5, GlyT begin to invade the maternal decidua where they associate with 73 
spiral arteries that deliver maternal blood to the placenta [14-16]. The majority of GlyT cells 74 
remain within the Jz and localising around channels that drain maternal blood from the 75 
placenta [14, 16, 17]. 76 
Studies in mutant mouse models indicate that placental glycogen content declines in 77 
the days before term [18-24], consistent with a role in supporting fetal growth during late 78 
gestation [14]. However, the dynamics of placental glycogen storage and mobilization 79 
during normal gestation in the mouse have not been formally quantitated to date. Similarly, 80 
little is known about the mechanism by which placental glycogen metabolism is regulated. 81 
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In particular, expression of glucose 6-phosphatase (G6pase) by GlyT cells is essential for 82 
release of glucose that is available for fetal uptake [25]. G6pase hydrolyses the polar 83 
phosphate group of glucose 6-phosphate, the end product of glycogenolysis, to yield 84 
glucose that can be transported out of the cell. Glucose production has been demonstrated 85 
in the human placenta at term [26], with increased G6Pase activity from week 28 of 86 
gestation [27], attributable to expression of the G6PC3 isoform [28]. However, G6pase 87 
expression has not been investigated in the mouse placenta to date.  88 
The aim of this work was to characterise the dynamics of placental glycogen storage 89 
in normal mouse gestation and explore the mechanisms regulating placental glycogen 90 
metabolism. We hypothesised that determining the expression profile of G6pase isoforms in 91 
the mouse placenta would provide insight as to the putative function of these energy stores 92 
as a source of glucose to support fetal growth. 93 
 94 
Materials and Methods 95 
Animals 96 
Animal studies and breeding were approved by the University of Cambridge Animal Welfare 97 
and Ethical Review Body in accordance with the Animals (Scientific Procedures) Act 1986. 98 
Male and female C57BL/6JOlaHsd mice were purchased from Envigo (UK) and housed 99 
throughout the study on a 12-hour light-dark cycle, receiving tap water and food (RM3(E), 100 
Special Diets Services) ad libitum. Females (aged 8-14 weeks) were mated with males (age 8-101 
20 weeks), with the day of plug discovery recorded as embryonic day 0.5 (E0.5). Pregnant 102 
females were killed by cervical dislocation at the indicated gestational stages. Fetuses and 103 
placentas were separated, briefly dried on tissue paper and weighed. The yolk sac was 104 
retained for determination of fetal sex by PCR as described previously [29]. 105 
 106 
Tissue processing 107 
Placentas were bisected, and each half weighed. Glycogen was extracted from one half of all 108 
placentas as described previously [30], and resuspended in 1 ml molecular biology grade 109 
water (Sigma). Glycogen extracts were diluted 1:4 and concentration determined using the 110 
phenol-sulphuric acid method [30]. For each litter, half of the remaining bisected placentas 111 
were fixed and processed for in situ hybridisation, whilst the other half were snap frozen 112 
and processed for gene expression analysis. One male and one female placenta from each 113 
litter was used for gene expression analysis and in situ hybridisation. For in situ 114 
hybridisation, placental tissue was fixed overnight at 4oC in phosphate-buffered 4% 115 
paraformaldehyde, paraffin-embedded and 6 m sections cut through the midline. 116 
 117 
Quantitative and semi-quantitative gene expression analysis 118 
Total RNA was extracted using the GenElute Mammalian Total RNA MiniPrep Kit (Sigma) 119 
with OnColumn DNase (Sigma) and 1 g reverse transcribed in a 25 l reaction containing 120 
500 ng Random Primers (Promega), 0.5 mM each dNTP (ThermoFisher) and 200U M-MLV 121 
Reverse Transcriptase, RNase H minus, Point Mutant (Promega). RT reactions were diluted 122 
15X in 10 mM Tris (pH8) and 2 l used as template in a 10 l qPCR reaction, comprising 0.5 123 
M of forward and reverse primer (Sigma); 0.2 mM each dNTP (ThermoFisher); 0.5U 124 
DreamTaq HotStart DNA Polymerase (ThermoFisher); 0.12X SybrGreen (Invitrogen) in 1X 125 
Buffer (2 mM MgCl2). Reactions were run in triplicate on a DNA Engine Opticon 2 (MJ 126 
Research). Thermocycler conditions were: 94oC for 2 minutes, followed by 35 cycles of 94oC 127 
for 20 seconds, 59oC for 20 seconds and 72oC for 30 seconds, with a plate read following 128 
each cycle, and a final elongation at 72oC for 5 minutes. Melting curve analysis was 129 
performed between 70 and 90oC in 0.5oC increments, with a 2 second hold at each 130 
temperature. Cycle threshold values were determined and relative expression calculated 131 
according to the 2-CT method [31, 32], normalising to the geometric mean of the reference 132 
genes Polr2a and Ubc [33]. Primer sequences and properties are provided in Supplementary 133 
Table 1. Semi-quantitative expression screening was conducted as described above, but 134 
omitting SybrGreen from the reaction mix, with reactions run on a MyCycler Thermocycler 135 
(BioRad) under the same conditions as above, but omitting the plate read and melting curve 136 
steps. PCR reactions were run on a 1% agarose gel and visualised with a UV transilluminator 137 
(BioRad). Primer sequences and properties are provided in Supplementary Table 2. 138 
 139 
In situ hybridisation 140 
The Tpbpa and Prl8a8 riboprobes have been described previously [34, 35]. The G6pc3 probe 141 
was generated by amplification of a 531-bp fragment from pooled E12.5-E18.5 placental 142 
cDNA using the primers 5’-TTTTCAGTTCTGCTTCCCCG-3’ and 5’-CAATACATGAGGCTGGCACC-143 
3’, which was subsequently cloned in to the pDrive vector (Qiagen). Plasmids were 144 
linearised and run-off DIG-labelled sense and antisense probes transcribed using the DIG 145 
RNA Labelling mix (Sigma). In situ hybridisation was performed on 6 m paraffin sections as 146 
described previously [36], incorporating modifications [37], with probe hybridisation at 60oC 147 
overnight. 148 
 149 
Statistical analyses 150 
Separate analyses were undertaken for placentas of male and female conceptuses to 151 
account for potential sexual dimorphism in glycogen storage [38]. Statistical analyses were 152 
performed by Two-Way ANOVA to identify main effects (gestational stage (PStage) and sex 153 
(PSex) and an interaction between these factors (PInt). Where an effect of gestational stage 154 
was indicated, the Dunnett’s test was used to perform separate planned comparisons for 155 
males and females, using E12.5 as the control stage. Where an effect of sex was identified, a 156 
two-tailed independent samples t-test was utilised to perform a planned comparison 157 
between males and females at each timepoint. Numerical data and summary statistics are 158 
provided in Supplementary Tables 3-9. 159 
 160 
Results 161 
Dynamics of fetal and placental growth 162 
Fetal weight increased ~14-fold between E12.5 and E18.5, with no difference observed 163 
between sex at any stage (Fig 1A). Placental weight increased ~50% from E12.5 to E15.5 164 
before declining slightly towards term (Fig 1B). Placental weight of female conceptuses was 165 
typically lower than that of males, achieving statistical significance at E15.5, E16.5 and E18.5 166 
(Fig 1B). The F:P ratio increased ~10-fold between E12.5 and E18.5, with no difference 167 
between sex observed (Fig 1C). Fetal and placental weights exhibited statistically significant 168 
positive correlation at E12.5, E14.5, E15.5 and E17.5 for males, but only at E17.5 and E18.5 169 
for females (Supp Fig 1). 170 
 171 
Dynamics of placental glycogen storage 172 
Total placental glycogen content increased ~5.5-fold between E12.5 and E15.5 before 173 
declining by a similar magnitude by E18.5 (Fig 1D). A similar trend was also observed when 174 
glycogen content was adjusted by placental weight (mg/g of placenta), showing that 175 
changes in glycogen content are not driven by changes in placental weight (Fig 1E). Whilst 176 
total glycogen content of male placentas was 17% greater than that of females at E15.5 (Fig 177 
1D), no other sex differences were observed. At its peak, placental glycogen represented 178 
~1.5% of placental weight, increasing from ~0.5% at E12.5 and declining to ~0.4% at E18.5 179 
(Fig 1F). Positive correlation between fetal weight and placental glycogen was statistically 180 
significant at E12.5, E14.5 and E17.5 for males and at E14.5, E16.5 and E18.5 for females (Fig 181 
2). Fetal weight and placental glycogen concentration exhibited statistically significant 182 
positive correlation only at E14.5 in males and at E14.5 and E16.5 in females (Supp Fig 2). 183 
Heavier placentas were consistently associated with greater total glycogen content (Supp 184 
Fig 3), but there was no correlation between placental weight and glycogen concentration 185 
(Supp Fig 4). 186 
 187 
Temporal expression of trophoblast lineage markers 188 
The volume of the Jz increases ~2.5-fold from E12.5 to E16.5 [39], which may be largely 189 
attributed to a ~200-fold increase in GlyT number within the Jz, with only a ~3.5-fold 190 
increase in SpT number [14]. Expression of the pan-Jz markers Tpbpa and Tpbpb increased 191 
from E12.5 to ~E15.5 before declining towards term (Fig 3A, B). Expression of Pcdh12, which 192 
is specific to GlyT from ~E7.5 [13], increased ~1.5 fold between E12.5 and E15.5, before 193 
declining towards term, although achieving significance only for males (Fig 3C). Expression 194 
of Gjb3, which is specific to GlyT from ~E13.5 and coincides with the transition from pre-195 
GlyT to mature GlyT, remained relatively unchanged throughout gestation (Fig3D). 196 
Expression of Aldh1a3, which is specific to GlyT from ~E8.5 [40], increased ~2-fold between 197 
E12.5 and E15.5 before declining towards term, with expression higher in male placentas 198 
until E15.5 (Fig 3E). Expression of Prl6a1, a marker of “non-migratory” GlyT [36], decreased 199 
~20-fold (Fig 3F), whereas expression of Prl7b1, a marker of “migratory” GlyT [36], was 200 
relatively unchanged (Fig 3G). In contrast, expression of the SpT markers Prl8a8 and Prl3a1 201 
increased ~12-fold and ~800-fold respectively (Fig 3H, I). For comparison, expression of 202 
lineage markers of the Lz, which increases in volume by ~4-fold between E12.5 and E18.5 203 
[39], are presented in Supp Fig 5. 204 
 205 
Temporal expression of glycogenesis and glycogenolysis pathway genes 206 
A number of transcriptional regulators have been implicated in regulating GlyT development 207 
and/or function [1]. We hypothesised that the transition from a predominantly glycogenic 208 
state to a glycogenolytic state during late gestation is driven by a down-regulation of genes 209 
encoding glycogenesis pathway enzymes (Fig 4) and a coincident upregulation of genes 210 
encoding glycogenolysis pathway enzymes (Fig 5). Consistent with this, expression of Gbe1, 211 
which encodes glycogen branching enzyme, declined ~40% from E12.5 to E15.5, thereafter 212 
remaining relatively constant to term (Fig 4G). We also observed a modest decline in 213 
expression of glycogen synthase isoform Gys1, although this achieved statistical significance 214 
only in females (Fig 4F). Whilst two isoforms of glycogen synthase exist (Gys1 and Gys2), we 215 
were unable to detect expression of the Gys2 isoform in the mouse placenta (Supp Fig 7). 216 
Expression of the muscle isoform of glycogen phosphorylase (Pygm), which catalyses the 217 
rate limiting step of glycogenolysis by releasing terminal glucose subunits from glycogen 218 
branches increased ~2-fold towards term (Fig 5D). 219 
 220 
Spatiotemporal expression of glucose 6 phosphatase 221 
Glucose 6-phosphatase expression in GlyT is essential if their glycogen stores are to provide 222 
a source of glucose that maintains fetal nutrient supply during late gestation as suggested 223 
[14]. Whilst placental expression of the G6pc and G6pc2 isoforms was not detected at any 224 
stage, we observed robust expression of G6pc3 from E12.5 until E18.5 (Supp Fig 8). 225 
Furthermore, expression of G6pc3 increased ~50% towards term, with expression in male 226 
placentas marginally higher than in female placentas at E17.5 (Fig 5F). As revealed by in situ 227 
hybridisation, G6pc3 expression was enriched in clusters of cells located within both the Jz 228 
(black arrow heads) and Db (white arrow heads) at E15.5 (Fig 6A, D). The morphological 229 
appearance, expression of the Jz marker Tpbpa (Fig 6B, E) and absence of the SpT marker 230 
Prl8a8 (Fig 6C, F), confirmed these as GlyT cells. Expression of G6pc3 was also observed in 231 
parietal trophoblast giant cells (P-TGC) (Fig 6D; asterisks), with low expression detected in 232 
some SpT and cells of the Lz (Fig 6D, G). Hybridisation with a G6pc3 sense probe did not 233 
yield any signal (Fig 6I). 234 
 235 
Discussion 236 
Dynamics of mouse placental glycogen storage 237 
Further to previous studies indicating a broad decline in placental glycogen content towards 238 
term, here we demonstrate that placental glycogen content peaks at E15.5, having 239 
increased by over 5-fold from E12.5, before declining by a similar magnitude at E18.5. At its 240 
maximum, placental glycogen represents ~1.5% of organ weight. This is comparable to the 241 
glycogen content of mouse liver (2-4% of organ weight) and substantially greater than in 242 
mouse skeletal muscle (~0.2% of organ weight) [41-43]. Whilst we observed modest 243 
correlation between placental glycogen content and fetal weight, this was not consistent 244 
throughout gestation or between sexes. This may be because placental glycogen is only one 245 
of many factors that ultimately determine fetal weight. Furthermore, since glucose is 246 
released into maternal blood, it will be available for uptake by all conceptuses of a litter, 247 
and as such correlation between individual fetal weights and placental glycogen content 248 
would not be expected. 249 
 250 
Expression of Jz lineage markers 251 
Despite the dramatic expansion in GlyT number [14], expression of the GlyT markers 252 
Pcdh12, Gjb3 and Aldh1a3 was increased only modestly. This suggests that the temporal 253 
expression of GlyT marker genes does not directly correlate with temporal changes in GlyT 254 
abundance. This may be explained if marker gene expression declines at the cellular level 255 
towards term. Consistent with this interpretation, analysis of Gjb3 expression by Northern 256 
blot indicated only a ~2-fold increase in expression at E17.5 relative to E10.5 [44]. Similarly, 257 
PCDH12 protein abundance did not appear overtly different between E12.5 and E17.5 [13]. 258 
However, more sophisticated methods will be required to explore expression of GlyT 259 
markers at the cellular level.  260 
Conversely, whilst the SpT population increases only ~4-fold between E12.5 and 261 
E16.5, expression of the SpT-specific markers Prl8a8 and Prl3a1 increased ~15-fold and 262 
~800-fold respectively. Such upregulation of Prl gene expression may be integral to 263 
facilitating the increased translation of placental hormones towards term. The functions of 264 
most non-classical members of the PRL family, and the receptors through which they act, 265 
remain unknown [45, 46]. However, recent studies have suggested a role for SpT-derived 266 
signals in modulating placental glycogen metabolism [19, 47, 48]. By analysing the temporal 267 
expression pattern of Prl family members, we identified that expression of Prl3c1, Prl7a2 268 
and Prl8a1, closely parallels the dynamics of placental glycogen storage (Supp Fig 9), 269 
potentially identifying key candidates. Whilst all three genes are strongly expressed by the 270 
SpT lineage [36], conditional knockouts will be required to test their effect on placental 271 
glycogen metabolism. 272 
 273 
Regulation of placental glycogen metabolism 274 
We hypothesised that the temporal dynamics of placental glycogen stores would be driven 275 
by altered transcription of genes encoding enzymes involved in glycogen metabolism. 276 
Consistent with this we found that expression of Gbe1 was downregulated ~40%, with a 277 
slight reduction in expression of Gys1 in females. This is consistent with findings in the spiny 278 
mouse, in which placental expression of Gbe1 and Gys1 was also down-regulated towards 279 
term [38], suggesting a conserved mechanism regulating placental glycogen breakdown. 280 
Taken together, these data suggest that a reduction in the extent of glycogen branching, 281 
alongside upregulation of the muscle isoform of glycogen phosphorylase underlies the 282 
depletion of placental glycogen stores towards term. 283 
 284 
Expression of glucose 6-phosphatase in the mouse placenta 285 
Glucose 6-phosphatase activity is essential for a cell to produce glucose for uptake by other 286 
cells, tissues or organs [49]. G6pase activity has been demonstrated in the human placenta 287 
[27] attributable to expression of the G6PC3 isoform [28]. In the mouse, expression of 288 
G6pc3 in skeletal muscle has been suggested to contribute to blood glucose homeostasis 289 
[50]. Here we demonstrate that G6pc3 expression in the mouse placenta is enriched in GlyT 290 
cells and increases ~50% by E18.5, coincident with the depletion of placental glycogen 291 
stores (Fig 1) and a ~50% reduction in GlyT number [14]. Placental expression of G6pase is 292 
consistent with a role for placental glycogen in providing a source of glucose to support fetal 293 
growth during late gestation. However, the ultimate destination of this glucose is not clear. 294 
The localisation of GlyT surrounding maternal arteries implies the potential for glucose to be 295 
released into maternal blood entering the placenta delivering nutrients for fetal uptake. 296 
Based on these cells accounting for ~30% of the total GlyT population [14] and an average 297 
litter size of 7, estimates of the glucose produced between E15.5 and E18.5 could contribute 298 
about 1-2% of the fetal requirement in late gestation [51]. The majority of GlyT surround 299 
channels that traverse the Jz draining maternal blood from the placenta, suggesting that 300 
glucose may be released into maternal blood leaving the placenta, and thus first be 301 
available for the mother. Based on these cells accounting for ~70% of the total GlyT 302 
population [14], estimates of the glucose produced between E15.5 and E18.5 could only 303 
account for <0.2% of the rate of maternal glucose utilisation during late pregnancy [51]. 304 
These calculations suggest that placental glycogen stores represent a somewhat 305 
inconsequential contribution to maternal and/or fetal glucose requirements. It is possible 306 
that placental glycogen stores are in a constant state of flux throughout gestation to ensure 307 
a constant supply of glucose to the fetus is maintained, and thus these calculations will 308 
underestimate the contribution of placental glycogen stores to maternal and/or fetal 309 
glucose requirements. Alternatively, as others have suggested [52], placental glycogen 310 
stores may instead provide energy store for the placenta itself. 311 
 312 
No evidence for sexual dimorphism in placental glycogen metabolism 313 
Whilst placental weight was typically lower in females and male placentas had 17% more 314 
glycogen than female placentas at E15.5, we did not observe any persistent differences in 315 
placental gene expression between placentas of male and female fetuses. However, with 316 
growing evidence that environmental and/or genetic perturbations may have sexually 317 
dimorphic effects, it is prudent to account for fetal sex in all phenotypic assessments in the 318 
context of genetic and/or environmental manipulation. 319 
 320 
Limitations 321 
A limitation of this study is that gene expression was assessed in whole-placental RNA 322 
extracts rather than separated placental regions. Whilst it is possible to generate Jz- and Lz-323 
enriched samples at some gestational stages, this is not possible earlier in gestation. A 324 
second limitation is that gene expression was assessed only at the mRNA level, and thus a 325 
role for post-translational modifications cannot currently be excluded. For instance, 326 
glycogen synthase (GYS1) and glycogen synthase kinase (GSK3) are both regulated by 327 
phosphorylation [53]. Nonetheless, our approach was designed to investigate the 328 
hypothesis that the temporal dynamics of placental glycogen content is driven by changes in 329 
transcriptional activity of glycogenesis and glycogenolysis pathway genes. 330 
 331 
Conclusions and future directions 332 
We have demonstrated that mouse placental glycogen stores peak at E15.5, thereafter 333 
declining towards term, coincident with a steady increase in G6pc3 expression. Whilst 334 
placental G6pase expression suggests the potential to produce glucose, it is beyond the 335 
scope of this work to elucidate the ultimate destination of placenta-derived glucose. Future 336 
work will focus on addressing this question. 337 
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Figure Legends 
Figure 1: Dynamics of fetal and placental growth and placental glycogen storage. Fetal (A) 
and placental (B) weight, and F:P ratios (C) at the indicated gestational stages. Total 
placental content (mg) (D) and glycogen per g of placenta (mg/g) (E) calculated as the total 
placental glycogen content adjusted by placental weight. F) Placental glycogen expressed as 
a percentage of placental weight. Weight data (for A, B, C) from at least 10 litters at each 
time-point: E12.5 (males: n = 33; females: n = 41), E14.5 (males: n = 43; females: n = 30), 
E15.5 (males: n = 32; females: n = 34), E16.5 (males: n = 40; females: n = 32), E17.5 (males: n 
= 42; females: n = 32), E18.5 (males: n = 30; females: n = 40). Glycogen data (for D, E, F) from 
at least 10 litters at each time-point: E12.5 (males: n = 31; females: n = 33), E14.5 (males: n = 
40; females: n = 28), E15.5 (males: n = 28; females: n = 31), E16.5 (males: n = 40; females: n 
= 32), E17.5 (males: n = 42; females: n = 32), E18.5 (males: n = 29; females: n = 37). All data 
is displayed as mean  SEM, with males plotted as a solid line and females plotted as a 
dashed line. Main effects were tested by Two-Way ANOVA for gestational stage (PStage) and 
sex (PSex) and an interaction between factors (PInt). A Dunnett’s test was used to compare 
each gestational stage to E12.5. Statistical significance between males and females at each 
timepoint was performed by t-test. Statistical significance is indicated by: a – significantly 
different to E12.5 for males; b – significantly different to E12.5 for females; c – males and 
females differ significantly at the indicated stage. 
 
Figure 2: Inconsistent correlation between fetal weight and total placental glycogen 
content. Scatter plots of total placental glycogen content (mg; x-axis) versus fetal weight (g; 
y-axis) for males (A, C, E, G, I, K) and females (B, D, F, H, J, L) at E12.5 (A, B), E14.5 (C, D), 
E15.5 (E, F), E16.5 (G, H), E17.5 (I, J), and E18.5 (K, L). Pearson’s r correlation coefficient and 
the associated p value are displayed. Data from at least 10 litters at each time-point: E12.5 
(males: n = 31; females: n = 33), E14.5 (males: n = 40; females: n = 28), E15.5 (males: n = 28; 
females: n = 31), E16.5 (males: n = 40; females: n = 32), E17.5 (males: n = 42; females: n = 
32), E18.5 (males: n = 29; females: n = 37). 
 
Figure 3: Temporal expression of key junctional zone lineage markers. Expression of 
established gene markers for junctional zone (Jz; Tpbpa (A), Tpbpb (B)), glycogen 
trophoblast (GlyT; Pcdh12 (C), Gjb3 (D), Aldh1a3 (E), Prl6a1 (F), Prl7b1 (G)) and 
Figure Legend
spongiotrophoblast (SpT; Prl8a8 (H), Prl3a1 (I)) lineages was assessed by quantitative qPCR. 
All data is displayed as mean  SEM, with data from males plotted as a solid line and from 
females as a dashed line. Main effects were tested by Two-Way ANOVA for gestational 
stage (PStage) and sex (PSex) and an interaction between factors (PInt). A Dunnett’s test was 
used to compare each gestational stage to E12.5. Statistical significance between males and 
females at each timepoint was performed by t-test. Statistical significance is indicated by: a 
– significantly different to E12.5 for males; b – significantly different to E12.5 for females; c 
– males and females differ significantly at the indicated stage. N = 10 individuals per sex, per 
timepoint, from 10 litters. 
 
Figure 4: Temporal expression of genes encoding glycogenesis pathway enzymes. A) 
Schematic of glycogenesis pathway showing enzymes and the genes that encode them. 
Temporal expression glycogenesis pathway genes Hk1 (B), Hk2 (C), Ugp2 (D), Gyg (E), Gys1 
(F), Gbe1 (G), Gsk3a (H) and Gsk3b (I). All data is displayed as mean  SEM, with data from 
males plotted as a solid line and from females as a dashed line. Main effects were tested by 
Two-Way ANOVA for gestational stage (PStage) and sex (PSex) and an interaction between 
factors (PInt). A Dunnett’s test was used to compare each gestational stage to E12.5. 
Statistical significance between males and females at each timepoint was performed by t-
test. Statistical significance is indicated by: a – significantly different to E12.5 for males; b – 
significantly different to E12.5 for females; c – males and females differ significantly at the 
indicated stage. N = 10 individuals per sex, per timepoint, from 10 litters. 
 
Figure 5: Temporal expression of genes encoding glycogenolysis pathway enzymes. A) 
Schematic of glycogenolysis pathway showing enzymes and the genes that encode them. 
Expression of the glycogenolysis pathway genes Pygb (B), Pygl (C), Pygm (D), Agl (E), and 
G6pc3 (F). All qPCR data is displayed as mean  SEM, with data from males plotted as a solid 
line and from females as a dashed line. Main effects were tested by Two-Way ANOVA for 
gestational stage (PStage) and sex (PSex) and an interaction between factors (PInt). A Dunnett’s 
test was used to compare each gestational stage to E12.5. Statistical significance between 
males and females at each timepoint was performed by t-test. Statistical significance is 
indicated by: a – significantly different to E12.5 for males; b – significantly different to E12.5 
for females; c – males and females differ significantly at the indicated stage. N = 10 
individuals per sex, per timepoint, from 10 litters. 
Figure 6: Spatial expression of G6pc3 in the E15.5 placenta. In situ hybridisation 
demonstrated expression of G6pc3 in the Jz and Decidua at E15.5 (A). G6pc3 positive cells 
were identified as glycogen cells based on morphology, expression of Tpbpa (B) and 
absence of Prl8a8 expression (C). D) Higher magnification of (A) reveals strong expression of 
G6pc3 in GlyT clusters within both the Jz (black arrows) and decidua (white arrows). G6pc3 
expression was also observed in P-TGCs (asterisks). (E) and (F) Higher magnification of (C 
B) and (C) respectively confirms the presence of Tpbpa and absence of Prl8a8 in G6pc3-
positive clusters. Low level G6pc3 expression was also observed in SpT and in scattered cells 
within the Lz (G), with Tpbpa staining showing the Jz:Lz boundary (H). No signal was 
detected with the G6pc3 sense probe (I). Scale bars: low magnification (A, B, C), 250 m; 
high magnification (D, E, F, G, H, I), 100 m. 
 
Supplementary Figure 1:  Contrasting correlation between fetal weight and placental 
weight between males and females. Scatter plots of total placental weight (mg; x-axis) 
versus fetal weight (g; y-axis) for males (A, C, E, G, I, K) and females (B, D, F, H, J, L) at E12.5 
(A, B), E14.5 (C, D), E15.5 (E, F), E16.5 (G, H), E17.5 (I, J), and E18.5 (K, L). Pearson’s r 
correlation coefficient and its associated p value are displayed. Data from at least 10 litters 
at each time-point: E12.5 (males: n = 33; females: n = 41), E14.5 (males: n = 43; females: n = 
30), E15.5 (males: n = 32; females: n = 34), E16.5 (males: n = 40; females: n = 32), E17.5 
(males: n = 42; females: n = 32), E18.5 (males: n = 30; females: n = 40). 
 
Supplementary Figure 2: No correlation between fetal weight and placental glycogen 
concentration. Scatter plots of placental glycogen concentration (mg/g; x-axis) versus fetal 
weight (g; y-axis) for males (A, C, E, G, I, K) and females (B, D, F, H, J, L) at E12.5 (A, B), E14.5 
(C, D), E15.5 (E, F), E16.5 (G, H), E17.5 (I, J), and E18.5 (K, L). Pearson’s r correlation 
coefficient and its associated p value are displayed. Data from at least 10 litters at each 
time-point: E12.5 (males: n = 31; females: n = 33), E14.5 (males: n = 40; females: n = 28), 
E15.5 (males: n = 28; females: n = 31), E16.5 (males: n = 40; females: n = 32), E17.5 (males: n 
= 42; females: n = 32), E18.5 (males: n = 29; females: n = 37). 
 
Supplementary Figure 3: Heavier placentas accumulate greater glycogen stores. Scatter 
plots of placental weight (mg; x-axis) versus total placental glycogen (mg; y-axis) for males 
(A, C, E, G, I, K) and females (B, D, F, H, J, L) at E12.5 (A, B), E14.5 (C, D), E15.5 (E, F), E16.5 
(G, H), E17.5 (I, J), and E18.5 (K, L). Pearson’s r correlation coefficient and its associated p 
value are displayed. Data from at least 10 litters at each time-point: E12.5 (males: n = 31; 
females: n = 33), E14.5 (males: n = 40; females: n = 28), E15.5 (males: n = 28; females: n = 
31), E16.5 (males: n = 40; females: n = 32), E17.5 (males: n = 42; females: n = 32), E18.5 
(males: n = 29; females: n = 37).  
 
Supplementary Figure 4: No correlation between placental weight and glycogen 
concentration. Scatter plots of placental weight (mg; x-axis) versus placental glycogen 
concentration (mg/g; y-axis) for males (A, C, E, G, I, K) and females (B, D, F, H, J, L) at E12.5 
(A, B), E14.5 (C, D), E15.5 (E, F), E16.5 (G, H), E17.5 (I, J), and E18.5 (K, L). Pearson’s r 
correlation coefficient and its associated p value are displayed. Data from at least 10 litters 
at each time-point: E12.5 (males: n = 31; females: n = 33), E14.5 (males: n = 40; females: n = 
28), E15.5 (males: n = 28; females: n = 31), E16.5 (males: n = 40; females: n = 32), E17.5 
(males: n = 42; females: n = 32), E18.5 (males: n = 29; females: n = 37).  
 
Supplementary Figure 5: Temporal expression of key labyrinth zone lineage markers. 
Expression of the pan-Lz marker Dlx3 (A), syncytiotrophoblast layer I (SynT-I) marker Syna 
(B), syncytiotrophoblast layer II (SynT-II) markers Gcm1 (C) and Synb (D), fetal endothelium 
marker Flk1 (E), and the VEGF receptor 1 Flt1 (F). All qPCR data is displayed as mean  SEM, 
with data from males plotted as a solid line and from females as a dashed line. Main effects 
were tested by Two-Way ANOVA for gestational stage (PStage) and sex (PSex) and an 
interaction between factors (PInt). A Dunnett’s test was used to compare each gestational 
stage to E12.5. Statistical significance between males and females at each timepoint was 
performed by t-test. Statistical significance is indicated by: a – significantly different to E12.5 
for males; b – significantly different to E12.5 for females; c – males and females differ 
significantly at the indicated stage. N = 10 individuals per sex, per timepoint, from 10 litters. 
 
Supplementary Figure 6: Expression of phosphoglucomutase genes. Expression of Pgm1 
(A), Pgm2 (B) and Pgm3 (C). All qPCR data is displayed as mean  SEM, with data from males 
plotted as a solid line and from females as a dashed line. Main effects were tested by Two-
Way ANOVA for gestational stage (PStage) and sex (PSex) and an interaction between factors 
(PInt). A Dunnett’s test was used to compare each gestational stage to E12.5. Statistical 
significance between males and females at each timepoint was performed by t-test. 
Statistical significance is indicated by: a – significantly different to E12.5 for males; b – 
significantly different to E12.5 for females; c – males and females differ significantly at the 
indicated stage. N = 10 individuals per sex, per timepoint, from 10 litters. 
 
Supplementary Figure 7: Gys1 and Gys2 sequences are highly homologous. A) Sequence 
alignment of the glycogen synthase isoforms Gys1 (top) and Gys2 (bottom) shows high 
sequence homology, with homologous sequence in black and mismatches in red. The entire 
Gys2 sequence is shown. The Gys1 sequence is truncated at nucleotide 2681 for space 
reasons (nucleotides 2682 – 3681 not shown). Locations of previously published (yellow) 
and novel (blue) primers highlighted. The forward primer utilised in this work spans a 12 bp 
deletion in the Gys1 sequence to ensure specificity for Gys2. B) Placental expression of Gys1 
was detected at all stages examined, but Gys2 was not expressed at any stage (C). Sample 
order: Lanes 1 – 6 = Pooled cDNA from E12.5, E14.5, E15.5, E16.5, E17.5, E18.5 placentas 
respectively. Lane 7 = positive control (pooled E18.5 fetal liver cDNA). Lane 8 = no template 
control (NTC). 
 
Supplementary Figure 8: PCR expression screen of glucose 6-phosphatase isoforms. 
Expression of the G6pc and G6pc2 glucose 6 phosphatase isoforms could not be detected in 
the mouse placenta, but robust expression of G6pc3 was observed at all stages examined. 
Pooled cDNA from E12.5, E14.5, E15.5, E16.5, E17.5, E18.5 placentas, was used as template 
alongside a positive control (E18.5 fetal liver cDNA for G6pc and G6pc3; cDNA reverse 
transcribed from C57BL/6 mouse pancreas RNA (AMS Biotechnology MR-313-C57) for 
G6pc2). NTC = no template control. 
 
Supplementary Figure 9: Temporal expression of Prl gene family members. Prl3c1 (A), 
Prl7a2 (B), Prl8a1 (C), Prl3b1 (D), Prl7c1 (E) and Prl8a9 (F) exhibited an initial increase in 
expression followed either by a decline (Prl3c1, Prl8a1, Prl7a2) or plateau (Prl3b1, Prl7c1, 
Prl8a9) towards term. Expression of Prl8a6 (G), Prl5a1 (H) and Prl2a1 (I) continued to 
increase towards term. Expression of Prl4a1 (J), Prl7a1 (K) and Prl7d1 (L) decreased from 
E12.5 to term. We did not characterise Prl3d, which is expressed only in parietal TGCs until 
~E10.5; Prl8a2, which is expressed solely in the decidua; or Prl2c, expression of which peaks 
at ~E9.5 before declining dramatically thereafter [27]. Although Prl2a1 and Prl7c1 are not 
expressed by the SpT lineage their temporal expression profiles were characterised for 
comparison as both genes are expressed by GlyT [27]. All qPCR data is displayed as mean  
SEM, with data from males plotted as a solid line and from females as a dashed line. Main 
effects were tested by Two-Way ANOVA for gestational stage (PStage) and sex (PSex) and an 
interaction between factors (PInt). A Dunnett’s test was used to compare each gestational 
stage to E12.5. Statistical significance between males and females at each timepoint was 
performed by t-test. Statistical significance is indicated by: a – significantly different to E12.5 
for males; b – significantly different to E12.5 for females; c – males and females differ 
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